Mumbai. The Bombay High Court on Thursday said Maharashtra needs to inform the Center that mucormycosis (black fungus) patients in the state’s Marathwada region are dying due to lack of necessary medicines for treatment.
Justices RV Ghuge and BU Debadwar of the Aurangabad bench of the High Court were told that patients in the Marathwada region were not getting proper treatment as the supply of amphotericin B was short. This medicine is used in the treatment of black fungus infection. The bench was hearing petitions related to the Kovid-19 epidemic. Advocate Satyajit Bora, who was appointed to assist the court, argued that patients were being given one or two injections daily while they needed to be given four to five injections daily.
He said that 124 people have lost their lives as a result of this. He said that even today the supply of medicine is 70 percent less than what is needed.
1178 cases of black fungus in Marathwada regionPublic prosecutor DR Kale told the court that at present there are 1178 cases of black fungus in the Marathwada region. Out of these, 669 patients are undergoing treatment while 385 have recovered from it while 124 patients have lost their lives so far.
Additional Solicitor General Anil Singh, appearing for the Centre, told the court that Maharashtra was allotted 68360 injections out of a total of 2.70 lakh injections.
It will take 20-25 days to increase the production of the drug
He said that pharmaceutical companies manufacturing this drug have been instructed to increase their production. The exercise to increase production will take 20 to 25 days.
Also read:- Maharashtra will be unlocked in 5 phases, where 5% positivity rate, there will be relief: Government
After hearing all the arguments, the court said, “Considering the situation, we find that the Government of Maharashtra has to apprise the Government of India about the situation, especially highlighting the increasing number of patients with Mucormycosis and the fact that Marathwada like Patients in the area are losing their lives due to the shortage of amphotericin B drug.”
The mortality rate of black fungus patients is very high
The court said that in view of 669 under-treatment patients and 124 deaths, the death rate is very high because patients are being given insufficient doses of the medicine. The court asked the state government to clearly tell through a chart in front of it by June 9, how many patients of black fungus are undergoing treatment, how many patients have become healthy and how many patients have lost their lives.
The court has also asked the state government to produce a chart showing the supply of amphotericin B drug between June 2 and June 9. The court has fixed June 10 as the next date of hearing in this case.